MusclePharm plans $1.4 million private placement of convertible note

Proceeds help enhance company's financial strength for future growth

By Devika Patel

Knoxville, Tenn., Dec. 10 - MusclePharm Corp. said it will raise $1.4 million through a convertible promissory note agreement with a single investor.

"We are very pleased with the successful completion of the agreement with the investor and believe this capital will support our capital requirements for growth," chief executive officer Brad Pyatt stated in a news release. "We appreciate our investor's confidence in MusclePharm as we continue to execute our long-term growth strategy."

The Denver-based company develops and manufactures a line of nutritional supplements.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.